로딩 중…
StockDiggingStockDigging

DRGEM Corporation

263690· KOSDAQ
₩4,925+1.76%
2026-09-18

Financials

Valuation Metrics

DRGEM Corporation's Market Cap is ₩558B. At end of 2025 it was ₩605B. Ranked #1703 of 2,421 in KR market (top 70%), #1030 of 1,640 on KOSDAQ (top 63%), #68 of 96 in Health Care Equipment & Services (top 71%) by Market Cap.

Investment Metrics(as of 2026-09-18)

MetricValue
Size
Market Cap55.78B KRW
Revenue109.45B KRW
Net Income12.28B KRW
Total Assets131.65B KRW
Net Assets98.07B KRW
Employees278
Value
P/E4.54x
P/B0.57x
PEG0.03x
P/S0.51x
EV/EBITDA4.83x
FCF Yield17.00%
Profitability
ROE12.52%
ROA9.33%
Op. Margin9.69%
Revenue Growth11.35%
Earnings Growth142.29%
Financial Health
Debt Ratio34.23%
Total Debt10.00B KRW
FCF9.48B KRW
Cash14.51B KRW
Current Ratio3.32x
Net Debt/EBITDA-0.42x
Dividend
Div. Yield3.61%
Div. Growth11.25%
Performance
1Y Return-19.13%
1M Return-1.50%
From 52W High-22.07%
1Y MDD-22.64%
Trading
Volume3,114 shares
Trading Value15.3M KRW
Foreign Own.15.54%
Per Share
EPS1,084 KRW
BPS8,659 KRW

Company Info

CEO 박정병
Employees 278
Founded 2003
HQ 경기도 광명시, KR

DRGEM, established in 2003 and listed on KOSDAQ in 2018, researches, develops, manufactures, and sells X-ray imaging devices for patient diagnosis. The company holds subsidiaries DRGEM America Inc. and Weihai Drgem Medical Equipment Company Limited. It sells various diagnostic analog and digital X-ray imaging devices through 250 dealers in 120 countries worldwide. DRGEM is headquartered in Gwangmyeong-si, Gyeonggi-do.